Sitting on a Pile of Cash 2.0? A Pharma with Strong Risk Benefits

Sitting on a Pile of Cash 2.0? A Pharma with Strong Risk Benefits

$MEIP MEI Pharma Inc. (NASDAQ:MEIP): this is an exponential Northside call, the sector analysts sees it having a best-in-class PI3Kδ inhibitor, which has demonstrated strong risk-benefit profile in Phase 1 lymphoma trials. MEIP broke out on 6 April and has confirmed it Bull move, the Support is Strong at 2.53 and the Resistance is NIL, […]

Wall Street’s Key Stock Analysts Research Report, All Buys

Wall Street’s Key Stock Analysts Research Report, All Buys

$BLMN, $MRVL, $MEIP, $PPL, $UNFI, $WSM These are all Buys if you can manage the risk. Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. These reports cover stocks to buy Below is our list for Monday, 1 June, as follows: Bloomin’ Brands Inc. (NASDAQ:BLMN) was raised to Buy from Hold and the […]